Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.54 |
| ▸ | USP2 | O75604 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.48 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | F11 | P03951 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.46 |
| ▸ | PDE5A | O76074 | 1/20 | 0.46 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9850189 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL19263962 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL4300188 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL12595098 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL13396034 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL13146116 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL12140889 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL4300564 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL4785477 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A | |
| SCHEMBL18256380 | 1.00 | PTPN1 (0.54) | PTPN1USP2POLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138433-A1 | DEVELOPMENT OF NOVEL CLOFARABINE ANALOGS FOR CANCER THERAPY | SOUTHERN RESEARCH INSTITUTE | 2023-05-04 | — | — | US | disclosed |
| WO-2023076392-A1 | DEVELOPMENT OF NOVEL CLOFARABINE ANALOGS FOR CANCER THERAPY | SOUTHERN RESEARCH INSTITUTE (US) | 2023-05-04 | — | — | WO | disclosed |
| EP-2404926-B1 | Preparation of 2-chloro-9-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-adenine | SCINOPHARM TAIWAN LTD (TW) | 2014-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138433-A1 | DEVELOPMENT OF NOVEL CLOFARABINE ANALOGS FOR CANCER THERAPY | THPO, BRCA1, TYMS | PTPN1 2749/4885USP2 3019/4885POLB 1836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.